OmniAb Inc.

OABI | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.58

+$0.11 (+2.46%)

At close: Sep 21, 2026, 4:00 PM ET

$4.60

+$0.02 (+0.44%)

Pre-market: Sep 22, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.46%

(1D)

Rating

Updated: Aug 10, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $663.97M

1D Range

4.52 4.63

52W Range

1.30 5.43

Valuation (TTM)

PE -12.72

PB 2.55

EV/EBITDA -24.78

Valuation (NTM)

Forward PE N/A

Forward PEG 0.56

Price Target $4

Cash Flow

FCF Yield -3.5%

SBC Adj. FCF Yield -6.1%

SBC Impact -75.0%

Margins

Gross Margin 50.5%

Operating Margin -125.8%

FCF Margin -60.4%

Growth (CAGR)

Revenue 3Y | 5Y -16.6% | 4.7%

Dil EPS 3Y | 5Y 24.7% | -22.8%

FCF 3Y | 5Y 34.7% | -18.9%

Returns

ROA -15.3%

ROE -16.6%

ROIC -17.2%

Financial Health

Net Cash

$33.08M

Current Ratio 4.80

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad s...

Sector Healthcare

Industry Biotechnology

Employees 89

IPO Date Sep 29, 2021

Website www.omniab.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 3, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Downside

-12.66%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞